Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2008 | 1 |
2013 | 1 |
2014 | 1 |
2015 | 1 |
2016 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Six-month compliance with antidepressant medication in the treatment of major depressive disorder.
Int Clin Psychopharmacol. 2008 Jan;23(1):36-42. doi: 10.1097/YIC.0b013e3282f1c1d8.
Int Clin Psychopharmacol. 2008.
PMID: 18090506
Long-term quality-of-life and functioning comparison of atomoxetine versus other standard treatment in pediatric attention-deficit/hyperactivity disorder.
Fuentes J, Danckaerts M, Cardo E, Puvanendran K, Berquin P, De Bruyckere K, Montoya A, Quail D, Escobar R.
Fuentes J, et al. Among authors: de bruyckere k.
J Clin Psychopharmacol. 2013 Dec;33(6):766-74. doi: 10.1097/JCP.0b013e31829c762b.
J Clin Psychopharmacol. 2013.
PMID: 23963057
Clinical Trial.
Item in Clipboard
Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.
Bushe C, Sobanski E, Coghill D, Berggren L, De Bruyckere K, Leppämäki S.
Bushe C, et al. Among authors: de bruyckere k.
CNS Drugs. 2016 Apr;30(4):317-34. doi: 10.1007/s40263-016-0323-x.
CNS Drugs. 2016.
PMID: 27055440
Clinical Trial.
Item in Clipboard
What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors?
Demyttenaere K, Albert A, Mesters P, Dewé W, De Bruyckere K, Sangeleer M.
Demyttenaere K, et al. Among authors: de bruyckere k.
J Clin Psychiatry. 2005 Jul;66(7):859-63. doi: 10.4088/jcp.v66n0708.
J Clin Psychiatry. 2005.
PMID: 16013901
Item in Clipboard
Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database.
De Bruyckere K, Bushe C, Bartel C, Berggren L, Kan CC, Dittmann RW.
De Bruyckere K, et al.
CNS Drugs. 2016 Jun;30(6):541-58. doi: 10.1007/s40263-016-0346-3.
CNS Drugs. 2016.
PMID: 27224994
Item in Clipboard
Safety and tolerability of atomoxetine in treatment of attention deficit hyperactivity disorder in adult patients: an integrated analysis of 15 clinical trials.
Camporeale A, Porsdal V, De Bruyckere K, Tanaka Y, Upadhyaya H, Deix C, Deberdt W.
Camporeale A, et al. Among authors: de bruyckere k.
J Psychopharmacol. 2015 Jan;29(1):3-14. doi: 10.1177/0269881114560183. Epub 2014 Nov 25.
J Psychopharmacol. 2015.
PMID: 25424623
Item in Clipboard
Cite
Cite